Xingbo Mo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xingbo Mo has a total of 226 co-authors. Here are the top co-authors by number of shared publications:
Huan Zhang
Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden; Department of Epidemiology, School of Public Health, Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, MOE Key Laboratory of Geriatric Diseases and Immunology, Suzhou Medical College of Soochow University, Suzhou, China
19 shared publications- Shu-Feng Lei
The Children’s Hospital of Soochow University, School of Public Health, Suzhou Medical College of Soochow University, Suzhou, P. R. China
16 shared publications Yong-Hong Zhang
Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Soochow University, 199 Renai Road, Suzhou, 215123, Jiangsu, People's Republic of China
15 shared publicationsXin Lu
Center for Genetic Epidemiology and Genomics School of Public Health Medical College of Soochow University Suzhou P. R. China
14 shared publicationsPei He
Center for Genetic Epidemiology and Genomics School of Public Health Medical College of Soochow University Suzhou P. R. China
10 shared publications- Fei-Yan Deng
The Children’s Hospital of Soochow University, School of Public Health, Suzhou Medical College of Soochow University, Suzhou, P. R. China
9 shared publications
Latest Publications
- Open Access
- 15 October 2026
- Published by Elsevier in American Journal of Obstetrics and Gynecology
Placental abruption as a marker of long-term maternal cardiovascular risk
- 15 October 2026
- Published by Elsevier in American Journal of Obstetrics and Gynecology
Open AccessPlacental abruption as a marker of long-term maternal cardiovascular risk
- Open Access
- 22 September 2026
- Published by Elsevier in eClinicalMedicine
- Vol. 100
Maternal autoimmune diseases during pregnancy and mortality up to young adulthood in offspring: a register-based cohort study
- 22 September 2026
- Published by Elsevier in eClinicalMedicine
- Vol. 100
Open AccessMaternal autoimmune diseases during pregnancy and mortality up to young adulthood in offspring: a register-based cohort study
- Open Access
- 22 April 2026
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (39) , 5822-5836
Pregnancy in women with autoimmune diseases and cardiovascular risk in the offspring: a Swedish population-based cohort study
Background and Aims: Maternal autoimmune diseases (AIDs) have been linked to adverse birth outcomes that may potentially increase cardiovascular disease (CVD) risk in offspring. However, whether maternal AIDs is associated with offspring CVD remains largely unexplored. This study aimed to examine whether intrauterine exposure to maternal AIDs is associated with offspring CVD up to early adulthood. Methods: This nationwide population-based cohort study included 1 455 645 live singleton births during 2001–2014 in Sweden and followed them to 31 December 2023. Associations between maternal AIDs and offspring CVD were evaluated using Cox proportional hazard models. Cousin analyses and analyses with paternal AID were conducted to assess shared genetic and familial environmental confounding. Results: During a median follow-up of 15.2 years (range, 0–23.7 years), 90 046 (6.2%) participants were exposed to maternal AIDs and 40 260 (2.8%) were diagnosed with CVD. Intrauterine exposure to maternal AIDs was associated with an increased risk of any CVD in offspring (hazard ratio 1.19, 95% confidence interval 1.14–1.24). Elevated CVD risks in offspring were observed across maternal AID categories. Paternal AIDs had a weaker association with offspring CVD than maternal AIDs; the associations in the cousin analyses persisted, though they were somewhat weaker than those in the main analyses. Conclusions: Maternal AIDs is associated with a moderately increased risk of CVD in childhood and early adulthood in offspring. These findings need to be interpreted with caution, as shared familial factors may partly contribute to the observed associations, and further studies are needed to clarify the mechanisms underlying the observed associations.
- 22 April 2026
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (39) , 5822-5836
Open AccessPregnancy in women with autoimmune diseases and cardiovascular risk in the offspring: a Swedish population-based cohort study
Background and Aims: Maternal autoimmune diseases (AIDs) have been linked to adverse birth outcomes that may potentially increase cardiovascular disease (CVD) risk in offspring. However, whether maternal AIDs is associated with offspring CVD remains largely unexplored. This study aimed to examine whether intrauterine exposure to maternal AIDs is associated with offspring CVD up to early adulthood. Methods: This nationwide population-based cohort study included 1 455 645 live singleton births during 2001–2014 in Sweden and followed them to 31 December 2023. Associations between maternal AIDs and offspring CVD were evaluated using Cox proportional hazard models. Cousin analyses and analyses with paternal AID were conducted to assess shared genetic and familial environmental confounding. Results: During a median follow-up of 15.2 years (range, 0–23.7 years), 90 046 (6.2%) participants were exposed to maternal AIDs and 40 260 (2.8%) were diagnosed with CVD. Intrauterine exposure to maternal AIDs was associated with an increased risk of any CVD in offspring (hazard ratio 1.19, 95% confidence interval 1.14–1.24). Elevated CVD risks in offspring were observed across maternal AID categories. Paternal AIDs had a weaker association with offspring CVD than maternal AIDs; the associations in the cousin analyses persisted, though they were somewhat weaker than those in the main analyses. Conclusions: Maternal AIDs is associated with a moderately increased risk of CVD in childhood and early adulthood in offspring. These findings need to be interpreted with caution, as shared familial factors may partly contribute to the observed associations, and further studies are needed to clarify the mechanisms underlying the observed associations.
- 15 December 2025
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
Psychiatric disorders and the risk of atrial fibrillation: a Swedish population-based cohort study
Aims: Atrial fibrillation (AF) is a growing public health concern, but its aetiology is not well understood. A few studies investigated the association of depression and anxiety with AF and yielded mixed results. Studies analysing the link of other psychiatric disorders (PDs) with AF risk are scarce. Herein, we investigated the association between a broad range of PDs and the risk of incident AF. Methods and results: We studied 3 815 546 parents of live-born children registered in the Swedish Medical Birth Register during 1973–2014 and followed them from 1 January 2001 to 31 December 2023. We used Cox proportional hazard models and flexible parametric survival models to estimate the associations of overall and 14 specific PD subtypes with the risk of incident AF. We used sibling comparisons to evaluate whether shared familial factors confounded the observed associations. Altogether 806 078 (21.13%) participants had at least one PD and 213 048 (5.58%) had a diagnosis of AF during the 82.6 million person-years follow-up. Overall PD and several types of PDs were associated with increased risks of AF. The adjusted hazard ratios and 95% confidence intervals for AF according to overall PD were 1.28 (1.27–1.29) and 1.32 (1.29–1.35) in the whole cohort and in the sibling analysis, respectively. The associations were generally strongest early in the follow-up, progressively weakened over time, but persisted through the whole follow-up. Conclusion: Several PDs were linked to increased risks of developing AF. Further studies are needed to replicate our findings and to understand the mechanisms underlying these associations.
- 15 December 2025
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
Psychiatric disorders and the risk of atrial fibrillation: a Swedish population-based cohort study
Aims: Atrial fibrillation (AF) is a growing public health concern, but its aetiology is not well understood. A few studies investigated the association of depression and anxiety with AF and yielded mixed results. Studies analysing the link of other psychiatric disorders (PDs) with AF risk are scarce. Herein, we investigated the association between a broad range of PDs and the risk of incident AF. Methods and results: We studied 3 815 546 parents of live-born children registered in the Swedish Medical Birth Register during 1973–2014 and followed them from 1 January 2001 to 31 December 2023. We used Cox proportional hazard models and flexible parametric survival models to estimate the associations of overall and 14 specific PD subtypes with the risk of incident AF. We used sibling comparisons to evaluate whether shared familial factors confounded the observed associations. Altogether 806 078 (21.13%) participants had at least one PD and 213 048 (5.58%) had a diagnosis of AF during the 82.6 million person-years follow-up. Overall PD and several types of PDs were associated with increased risks of AF. The adjusted hazard ratios and 95% confidence intervals for AF according to overall PD were 1.28 (1.27–1.29) and 1.32 (1.29–1.35) in the whole cohort and in the sibling analysis, respectively. The associations were generally strongest early in the follow-up, progressively weakened over time, but persisted through the whole follow-up. Conclusion: Several PDs were linked to increased risks of developing AF. Further studies are needed to replicate our findings and to understand the mechanisms underlying these associations.
- 29 August 2025
- Published by Springer Nature in Hypertension Research
- Vol. 48 (11) , 2969-2978
Deciphering genetic associations with blood pressure in peripheral blood mononuclear cells through single-cell transcriptomic profiling
Functional genes within genomic loci associated with blood pressure (BP) identified by genome-wide association studies (GWASs) are cell type-specific. This study aims to identify such genes in immune cells by employing single-cell transcriptomic analysis in peripheral blood mononuclear cells (PBMCs). By integration of single-cell transcriptomic sequencing data with GWAS (1 million individuals) findings using the summary data–based Mendelian randomization (SMR) method, we identified candidate BP-associated genes across diverse immune cell subsets. We performed single-cell RNA sequencing on PBMCs (111,694 cells) from 10 individuals (three hypertensive, three pre-hypertensive and four normotensive), identifying gene expression in distinct cell types associated with hypertension. Finally, publicly available data from eight individuals were utilized for validation (28,919 cells). Single-cell expression quantitative trait locus analysis revealed that the BP-associated SNPs were associated with expression levels of 353 genes across 14 distinct immune cell types. The single-cell SMR analysis identified 566 significant associations between expression levels of 159 genes and BP. The analysis of data from hypertensive and normotensive individuals unveils 99 differential expression genes across various immune cell types, with ERAP2 exhibiting significant dysregulation in CD8+ T cells and natural killer cells. These findings were corroborated through validation analyses. Our study contributes to a comprehensive understanding of the intricate relationships between genetic variation, immune cell-specific gene expression, and BP. We demonstrate a compelling association between ERAP2 expression levels in CD8+ T cells and natural killer cells and BP.
- 29 August 2025
- Published by Springer Nature in Hypertension Research
- Vol. 48 (11) , 2969-2978
Deciphering genetic associations with blood pressure in peripheral blood mononuclear cells through single-cell transcriptomic profiling
Functional genes within genomic loci associated with blood pressure (BP) identified by genome-wide association studies (GWASs) are cell type-specific. This study aims to identify such genes in immune cells by employing single-cell transcriptomic analysis in peripheral blood mononuclear cells (PBMCs). By integration of single-cell transcriptomic sequencing data with GWAS (1 million individuals) findings using the summary data–based Mendelian randomization (SMR) method, we identified candidate BP-associated genes across diverse immune cell subsets. We performed single-cell RNA sequencing on PBMCs (111,694 cells) from 10 individuals (three hypertensive, three pre-hypertensive and four normotensive), identifying gene expression in distinct cell types associated with hypertension. Finally, publicly available data from eight individuals were utilized for validation (28,919 cells). Single-cell expression quantitative trait locus analysis revealed that the BP-associated SNPs were associated with expression levels of 353 genes across 14 distinct immune cell types. The single-cell SMR analysis identified 566 significant associations between expression levels of 159 genes and BP. The analysis of data from hypertensive and normotensive individuals unveils 99 differential expression genes across various immune cell types, with ERAP2 exhibiting significant dysregulation in CD8+ T cells and natural killer cells. These findings were corroborated through validation analyses. Our study contributes to a comprehensive understanding of the intricate relationships between genetic variation, immune cell-specific gene expression, and BP. We demonstrate a compelling association between ERAP2 expression levels in CD8+ T cells and natural killer cells and BP.
- 31 October 2024
- Published by Elsevier in Molecular Immunology
- Vol. 175, 165-175
Deciphering cell-specific genetic insights: Unraveling the immunogenetic landscape of systemic lupus erythematosus
- 31 October 2024
- Published by Elsevier in Molecular Immunology
- Vol. 175, 165-175
Deciphering cell-specific genetic insights: Unraveling the immunogenetic landscape of systemic lupus erythematosus
- 4 September 2024
- Published by Taylor & Francis in Immunological Investigations
- Vol. 53 (8) , 1264-1278
Genome-Wide Identification of Cell Type-Specific Susceptibility Genes for SLE Through the Analysis of RNA Modification-Associated SNPs
IntroductionThis study aimed to elucidate the functional genes associated with systemic lupus erythematosus (SLE) in various cell types through the utilization of RNAm-SNPs.MethodsUtilizing large-scale genetic data, we identified associations between RNAm-SNPs and SLE. The association between RNAm-SNPs and bulk and single-cell mRNA expression (eQTL) and protein levels (pQTL) were examined. Mendelian randomization and differential expression analyses were conducted to explore the links between gene expression, protein levels, and SLE.ResultsWe identified 41 RNAm-SNPs that were significantly associated with SLE. The GWAS signals exhibited notable enrichment in m6A-SNPs and m7G-SNPs. These RNAm-SNPs showed both eQTL and pQTL effects. In our single-cell analysis, 16 RNAm-SNPs exhibited associations with gene expression levels across 13 distinct cell types, including HLA-A, HLA-B, HLA-C, HLA-DQA1, HLA-DQB1, HLA-DRB1 and IRF7. We identified 58 noteworthy associations between the expression levels of 20 genes and SLE across 12 distinct immune cell types. Notably, HLA-DQB1, HLA-DRB1 and IRF7 exhibited abnormalities in CD8+ T cells, IRF7 displayed abnormal expression in CD4+ T cells, while HLA-DRB1 and IRF7 were also distinctly perturbed in natural killer cells.DiscussionThis study advances our understanding of the genetic basis of SLE by highlighting the significance of RNAm-SNPs and immune cell gene expression in SLE.
- 4 September 2024
- Published by Taylor & Francis in Immunological Investigations
- Vol. 53 (8) , 1264-1278
Genome-Wide Identification of Cell Type-Specific Susceptibility Genes for SLE Through the Analysis of RNA Modification-Associated SNPs
IntroductionThis study aimed to elucidate the functional genes associated with systemic lupus erythematosus (SLE) in various cell types through the utilization of RNAm-SNPs.MethodsUtilizing large-scale genetic data, we identified associations between RNAm-SNPs and SLE. The association between RNAm-SNPs and bulk and single-cell mRNA expression (eQTL) and protein levels (pQTL) were examined. Mendelian randomization and differential expression analyses were conducted to explore the links between gene expression, protein levels, and SLE.ResultsWe identified 41 RNAm-SNPs that were significantly associated with SLE. The GWAS signals exhibited notable enrichment in m6A-SNPs and m7G-SNPs. These RNAm-SNPs showed both eQTL and pQTL effects. In our single-cell analysis, 16 RNAm-SNPs exhibited associations with gene expression levels across 13 distinct cell types, including HLA-A, HLA-B, HLA-C, HLA-DQA1, HLA-DQB1, HLA-DRB1 and IRF7. We identified 58 noteworthy associations between the expression levels of 20 genes and SLE across 12 distinct immune cell types. Notably, HLA-DQB1, HLA-DRB1 and IRF7 exhibited abnormalities in CD8+ T cells, IRF7 displayed abnormal expression in CD4+ T cells, while HLA-DRB1 and IRF7 were also distinctly perturbed in natural killer cells.DiscussionThis study advances our understanding of the genetic basis of SLE by highlighting the significance of RNAm-SNPs and immune cell gene expression in SLE.
- Open Access
- 3 September 2024
- Published by Wiley in Chronic Diseases and Translational Medicine
- Vol. 10 (4) , 327-339
Association of cardiorenal biomarkers with mortality in metabolic syndrome patients: A prospective cohort study from NHANES
Objectives: Approximately 20%–25% of the global adult population is affected by metabolic syndrome (MetS), highlighting its status as a major public health concern. This study aims to investigate the predictive value of cardiorenal biomarkers on mortality among patients with MetS, thus optimizing treatment strategies.Methods: Utilizing data from the National Health and Nutrition Examination Survey (NHANES) cycles between 1999 and 2004, we conducted a prospective cohort study involving 2369 participants diagnosed with MetS. We evaluated the association of cardiac and renal biomarkers with all‐cause and cardiovascular disease (CVD) mortality, employing weighted Cox proportional hazards models. Furthermore, machine learning models were used to predict mortality outcomes based on these biomarkers.Results: Among 2369 participants in the study cohort, over a median follow‐up period of 17.1 years, 774 (32.67%) participants died, including 260 (10.98%) from CVD. The highest quartiles of cardiac biomarkers (N‐terminal pro‐B‐type natriuretic peptide [NT‐proBNP]) and renal biomarkers (beta‐2 microglobulin, [β2M]) were significantly associated with increased risks of all‐cause mortality (hazard ratios [HRs] ranging from 1.94 to 2.06) and CVD mortality (HRs up to 2.86), after adjusting for confounders. Additionally, a U‐shaped association was observed between high‐sensitivity cardiac troponin T (Hs‐cTnT), creatinine (Cr), and all‐cause mortality in patients with MetS. Machine learning analyses identified Hs‐cTnT, NT‐proBNP, and β2M as important predictors of mortality, with the CatBoost model showing superior performance (area under the curve [AUC] = 0.904).Conclusion: Cardiac and renal biomarkers are significant predictors of mortality in MetS patients, with Hs‐cTnT, NT‐proBNP, and β2M emerging as crucial indicators. Further research is needed to explore intervention strategies targeting these biomarkers to improve clinical outcomes.
- 3 September 2024
- Published by Wiley in Chronic Diseases and Translational Medicine
- Vol. 10 (4) , 327-339
Open AccessAssociation of cardiorenal biomarkers with mortality in metabolic syndrome patients: A prospective cohort study from NHANES
Objectives: Approximately 20%–25% of the global adult population is affected by metabolic syndrome (MetS), highlighting its status as a major public health concern. This study aims to investigate the predictive value of cardiorenal biomarkers on mortality among patients with MetS, thus optimizing treatment strategies.Methods: Utilizing data from the National Health and Nutrition Examination Survey (NHANES) cycles between 1999 and 2004, we conducted a prospective cohort study involving 2369 participants diagnosed with MetS. We evaluated the association of cardiac and renal biomarkers with all‐cause and cardiovascular disease (CVD) mortality, employing weighted Cox proportional hazards models. Furthermore, machine learning models were used to predict mortality outcomes based on these biomarkers.Results: Among 2369 participants in the study cohort, over a median follow‐up period of 17.1 years, 774 (32.67%) participants died, including 260 (10.98%) from CVD. The highest quartiles of cardiac biomarkers (N‐terminal pro‐B‐type natriuretic peptide [NT‐proBNP]) and renal biomarkers (beta‐2 microglobulin, [β2M]) were significantly associated with increased risks of all‐cause mortality (hazard ratios [HRs] ranging from 1.94 to 2.06) and CVD mortality (HRs up to 2.86), after adjusting for confounders. Additionally, a U‐shaped association was observed between high‐sensitivity cardiac troponin T (Hs‐cTnT), creatinine (Cr), and all‐cause mortality in patients with MetS. Machine learning analyses identified Hs‐cTnT, NT‐proBNP, and β2M as important predictors of mortality, with the CatBoost model showing superior performance (area under the curve [AUC] = 0.904).Conclusion: Cardiac and renal biomarkers are significant predictors of mortality in MetS patients, with Hs‐cTnT, NT‐proBNP, and β2M emerging as crucial indicators. Further research is needed to explore intervention strategies targeting these biomarkers to improve clinical outcomes.
- 31 July 2024
- Published by Springer Nature in Immunogenetics
- Vol. 76 (5-6) , 291-304
Decoding the genetic landscape of juvenile dermatomyositis: insights from phosphorylation-associated single nucleotide polymorphisms
Genome-wide association studies (GWASs) have identified genetic susceptibility loci associated with juvenile dermatomyositis (JDM). Single nucleotide polymorphisms related to phosphorylation (phosSNPs) are critical nonsynonymous mutations exerting substantial influence on gene expression regulation. The aim of this study was to identify JDM susceptibility genes in the GWAS loci by the use of phosSNPs. We explored quantitative trait loci (QTLs) among the phosSNPs associated with JDM using data from eQTL (bulk tissues and single-cell) and pQTL studies. For gene expression and protein levels significantly influenced by JDM-associated phosSNPs, we assessed their associations with JDM through MR analyses. Additionally, we conducted differential expression gene analyses, incorporating single-cell transcriptomic profiling of 6 JDM cases and 11 juvenile controls (99,396 cells). We identified 31 phosSNPs situated in the 6p21 locus that were associated with JDM. Half of these phosSNPs showed effects on gene expression in various cells and circulating protein levels. In MR analyses, we established associations between the expression levels of pivotal JDM-associated genes, including MICB, C4A, HLA-DRB1, HLA-DRB5, and PSMB9, in skin, muscle, or blood cells and circulating levels of C4A, with JDM. Utilizing single-cell eQTL data, we identified a total of 276 association signals across 14 distinct immune cell types for 28 phosSNPs. Further insights were gained through single-cell differential expression analysis, revealing differential expression of PSMB9, HLA-A, HLA-B, HLA-C, HLA-DPB1, HLA-DQA1, HLA-DQB1, and HLA-DRB1 in immune cells. The present study pinpointed phosSNPs within susceptibility genes for JDM and unraveled the intricate relationships among these SNPs, gene expression levels, and JDM.
- 31 July 2024
- Published by Springer Nature in Immunogenetics
- Vol. 76 (5-6) , 291-304
Decoding the genetic landscape of juvenile dermatomyositis: insights from phosphorylation-associated single nucleotide polymorphisms
Genome-wide association studies (GWASs) have identified genetic susceptibility loci associated with juvenile dermatomyositis (JDM). Single nucleotide polymorphisms related to phosphorylation (phosSNPs) are critical nonsynonymous mutations exerting substantial influence on gene expression regulation. The aim of this study was to identify JDM susceptibility genes in the GWAS loci by the use of phosSNPs. We explored quantitative trait loci (QTLs) among the phosSNPs associated with JDM using data from eQTL (bulk tissues and single-cell) and pQTL studies. For gene expression and protein levels significantly influenced by JDM-associated phosSNPs, we assessed their associations with JDM through MR analyses. Additionally, we conducted differential expression gene analyses, incorporating single-cell transcriptomic profiling of 6 JDM cases and 11 juvenile controls (99,396 cells). We identified 31 phosSNPs situated in the 6p21 locus that were associated with JDM. Half of these phosSNPs showed effects on gene expression in various cells and circulating protein levels. In MR analyses, we established associations between the expression levels of pivotal JDM-associated genes, including MICB, C4A, HLA-DRB1, HLA-DRB5, and PSMB9, in skin, muscle, or blood cells and circulating levels of C4A, with JDM. Utilizing single-cell eQTL data, we identified a total of 276 association signals across 14 distinct immune cell types for 28 phosSNPs. Further insights were gained through single-cell differential expression analysis, revealing differential expression of PSMB9, HLA-A, HLA-B, HLA-C, HLA-DPB1, HLA-DQA1, HLA-DQB1, and HLA-DRB1 in immune cells. The present study pinpointed phosSNPs within susceptibility genes for JDM and unraveled the intricate relationships among these SNPs, gene expression levels, and JDM.
- Open Access
- 30 April 2024
- Published by Wiley in Chronic Diseases and Translational Medicine
- Vol. 10 (2) , 118-129
Unveiling blood pressure‐associated genes in aortic cells through integrative analysis of GWAS and RNA modification‐associated variants
Background: Genome‐wide association studies (GWAS) have identified more than a thousand loci for blood pressure (BP). Functional genes in these loci are cell‐type specific. The aim of this study was to elucidate potentially functional genes associated with BP in the aorta through the utilization of RNA modification‐associated single‐nucleotide polymorphisms (RNAm‐SNPs).Methods: Utilizing large‐scale genetic data of 757,601 individuals from the UK Biobank and International Consortium of Blood Pressure consortium, we identified associations between RNAm‐SNPs and BP. The association between RNAm‐SNPs, gene expression, and BP were examined.Results: A total of 355 RNAm‐SNPs related to m6A, m1A, m5C, m7G, and A‐to‐I modification were associated with BP. The related genes were enriched in the pancreatic secretion pathway and renin secretion pathway. The BP GWAS signals were significantly enriched with m6A‐SNPs, highlighting the potential functional relevance of m6A in physiological processes influencing BP. Notably, m6A‐SNPs in CYP11B1, PDE3B, HDAC7, ACE, SLC4A7, PDE1A, FRK, MTHFR, NPPA, CACNA1D, and HDAC9 were identified. Differential methylation and differential expression of the BP genes in FTO‐overexpression and METTL14‐knockdown vascular smooth muscle cells were detected. RNAm‐SNPs were associated with ascending and descending aorta diameter and the genes showed differential methylation between aortic dissection (AD) cases and controls. In scRNA‐seq study, we identified ARID5A, HLA‐DPB1, HLA‐DRA, IRF1, LINC01091, MCL1, MLF1, MLXIPL, NAA16, NADK, RERG, SRM, and USP53 as differential expression genes for AD in aortic cells.Conclusion: The present study identified RNAm‐SNPs in BP loci and elucidated the associations between the RNAm‐SNPs, gene expression, and BP. The identified BP‐associated genes in aortic cells were associated with AD.
- 30 April 2024
- Published by Wiley in Chronic Diseases and Translational Medicine
- Vol. 10 (2) , 118-129
Open AccessUnveiling blood pressure‐associated genes in aortic cells through integrative analysis of GWAS and RNA modification‐associated variants
Background: Genome‐wide association studies (GWAS) have identified more than a thousand loci for blood pressure (BP). Functional genes in these loci are cell‐type specific. The aim of this study was to elucidate potentially functional genes associated with BP in the aorta through the utilization of RNA modification‐associated single‐nucleotide polymorphisms (RNAm‐SNPs).Methods: Utilizing large‐scale genetic data of 757,601 individuals from the UK Biobank and International Consortium of Blood Pressure consortium, we identified associations between RNAm‐SNPs and BP. The association between RNAm‐SNPs, gene expression, and BP were examined.Results: A total of 355 RNAm‐SNPs related to m6A, m1A, m5C, m7G, and A‐to‐I modification were associated with BP. The related genes were enriched in the pancreatic secretion pathway and renin secretion pathway. The BP GWAS signals were significantly enriched with m6A‐SNPs, highlighting the potential functional relevance of m6A in physiological processes influencing BP. Notably, m6A‐SNPs in CYP11B1, PDE3B, HDAC7, ACE, SLC4A7, PDE1A, FRK, MTHFR, NPPA, CACNA1D, and HDAC9 were identified. Differential methylation and differential expression of the BP genes in FTO‐overexpression and METTL14‐knockdown vascular smooth muscle cells were detected. RNAm‐SNPs were associated with ascending and descending aorta diameter and the genes showed differential methylation between aortic dissection (AD) cases and controls. In scRNA‐seq study, we identified ARID5A, HLA‐DPB1, HLA‐DRA, IRF1, LINC01091, MCL1, MLF1, MLXIPL, NAA16, NADK, RERG, SRM, and USP53 as differential expression genes for AD in aortic cells.Conclusion: The present study identified RNAm‐SNPs in BP loci and elucidated the associations between the RNAm‐SNPs, gene expression, and BP. The identified BP‐associated genes in aortic cells were associated with AD.